(Q38356907)

2 September 2017

Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD1152. (English)

1 reference

2 September 2017

J Guo

1

1 reference

2 September 2017

M G Anderson

2

1 reference

2 September 2017

P Tapang

3

1 reference

2 September 2017

J P Palma

4

1 reference

2 September 2017

L E Rodriguez

5

1 reference

2 September 2017

A Niquette

6

1 reference

2 September 2017

J Li

7

1 reference

2 September 2017

J J Bouska

8

1 reference

2 September 2017

G Wang

9

1 reference

2 September 2017

D Semizarov

10

1 reference

2 September 2017

D H Albert

11

1 reference

2 September 2017

C K Donawho

12

1 reference

2 September 2017

K B Glaser

13

1 reference

2 September 2017

O J Shah

14

1 reference

2 September 2017

3 February 2009

1 reference

The Pharmacogenomics Journal

2 September 2017

1 reference

2 September 2017

9

1 reference

2 September 2017

90-102

1 reference

2 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/tpj.2008.20

2 September 2017

0 references

cites work

The cellular geography of aurora kinases

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Aurora kinases in spindle assembly and chromosome segregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Aurora-A - a guardian of poles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Mitotic mechanics: the auroras come into view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Molecular basis of drug resistance in aurora kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Cross-talk between signalling pathways and the multidrug resistant protein MDR-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Regional activation of chromosomal arm 7q with and without gene amplification in taxane-selected human ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

ABCG2 expression, function, and promoter methylation in human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.20

21 January 2018

Identifiers

DOI

10.1038/TPJ.2008.20

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference